1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. FDA approves Brilinta for ACSs
Cardio-PulmonaryClinical TopicsDrugs and DevicesHealthcare & TechnologyNewsWeb Exclusives

FDA approves Brilinta for ACSs

Share

The U.S. Food and Drug Administration (FDA) has approved Brilinta (ticarelor) for reducing cardiovascular death and heart attack in patients with acute coronary syndromes (ACSs). Read more..

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts